Questions and Answers on Drug Master Files (DMFs) and Drug Substances Part I
FDA presenters answer questions regarding the posters and presentations given at the Drug Master File (DMF) and Drug Substance Workshop on March 3-4, 2021.
View Q&A webinar page: https://www.fda.gov/drugs/news-events-human-drugs/drug-master-file-dmf-and-drug-substance-question-and-answer-webinar-following-march-3-4-2021
View conference and poster presentations: https://www.fda.gov/drugs/news-events-human-drugs/drug-master-file-dmf-and-drug-substance-workshop-03032021-03042021
--------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2021 Playlist - https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn - https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cderbsbialearn
Twitter - https://twitter.com/FDA_Drug_Info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
Видео Questions and Answers on Drug Master Files (DMFs) and Drug Substances Part I канала U.S. Food and Drug Administration
View Q&A webinar page: https://www.fda.gov/drugs/news-events-human-drugs/drug-master-file-dmf-and-drug-substance-question-and-answer-webinar-following-march-3-4-2021
View conference and poster presentations: https://www.fda.gov/drugs/news-events-human-drugs/drug-master-file-dmf-and-drug-substance-workshop-03032021-03042021
--------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2021 Playlist - https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn - https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cderbsbialearn
Twitter - https://twitter.com/FDA_Drug_Info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
Видео Questions and Answers on Drug Master Files (DMFs) and Drug Substances Part I канала U.S. Food and Drug Administration
Показать
Комментарии отсутствуют
Информация о видео
14 апреля 2021 г. 19:26:09
01:21:15
Другие видео канала
CMC Considerations for CAR T Cell Product DevelopmentResponses to Submitted Poster Questions - Drug Master File (DMF) and Drug Substance WorkshopPublic Meeting: Patient-Focused Drug Development for Systemic SclerosisEvaluation of Metal Impurities in Drug SubstancesUSP Pending Monograph Process and USP compliance for IndustryCommon CMC Issues in Type II DMFs and How to Avoid ThemDrug Substance Postapproval Changes Guidance: Determination of Impurity Profile EquivalencePublic Meeting: Patient-Focused Drug Development for VitiligoLASIK Surgery and its RisksEstablishment Registration and Drug Listing Compliance Program – DRLS Workshop 2020Clinical Pharmacology Regulatory Sciences in Drug Development and Precision MedicineVaccines and Related Biological Products Advisory Committee - 12/10/2020Closing Remarks from Division of Lifecycle API David SkanchyFDA Data Dashboard How-to: Using Maps Zoom/PanStakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21FDA Data Dashboard How-to: Performing Data SearchesJoint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine - 4/13/2021Cellular, Tissue and Gene Therapies Advisory Committee (CTGT) MeetingStakeholder Call: COVID-19 Testing Update – 3/1/2021Communication Best Practices – Interacting with Regulatory Project Managers in CDER/ORO